BioSapien

About

BioSapien is a biotech startup focusing on developing a 3D printed drug delivery platform to provide FDA approved drugs.

New York,New York,United States
1 - 10

Highlights

Details

Last Funding Type: Grant
Last Funding Money Raised: $256K
Industries: 3D Printing,3D Technology,Biopharma,Biotechnology,Pharmaceutical
Founded date: Jun 1, 2018
Number Of Employee: 1 - 10
Operating Status: Active
Legal Name: BioSapien Inc
Also Known As: BioSapien

BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline of indications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$37.05M

BioSapien has raised a total of $37.05M in funding over 2 rounds. Their latest funding was raised on Nov 1, 2022 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 1, 2022	Series A	$35M	3	—	—	Detail
Nov 11, 2021	Grant	$256K	1	National Science Foundation	—	Detail
Nov 11, 2021	Seed	$1.80M	11	SOSV	—	Detail
Jan 1, 2021	Series Unknown	—	1	—	—	Detail
Jan 20, 2020	Convertable Note	—	2	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

2

15

BioSapien is funded by 15 investors. National Science Foundation and IndieBio are the most recent investors.

Investor Name	Lead Investor	Funding Round
National Science Foundation	Yes	Grant
IndieBio	—	Series A
North West Quadrant Ventures ( NWQ Ventures)	—	Series A
SOSV	—	Series A
Cedas Foundation	—	Seed
Harbr	—	Seed
Beni VC	—	Seed
George and Saul	—	Seed
Hikma Ventures	—	Seed
Infinity Capital	—	Seed